- Home
- SPOK vs NPCE Comparison
SPOK vs NPCE Comparison
Compare SPOK & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPOK
- NPCE
- Stock Information
- Founded
- SPOK 2004
- NPCE 1997
- Country
- SPOK United States
- NPCE United States
- Employees
- SPOK N/A
- NPCE N/A
- Industry
- SPOK Telecommunications Equipment
- NPCE Medical Specialities
- Sector
- SPOK Telecommunications
- NPCE Health Care
- Exchange
- SPOK Nasdaq
- NPCE Nasdaq
- Market Cap
- SPOK 379.1M
- NPCE 292.9M
- IPO Year
- SPOK 1992
- NPCE 2021
- Fundamental
- Price
- SPOK $18.04
- NPCE $9.15
- Analyst Decision
- SPOK Hold
- NPCE Strong Buy
- Analyst Count
- SPOK 1
- NPCE 6
- Target Price
- SPOK $15.00
- NPCE $16.67
- AVG Volume (30 Days)
- SPOK 170.2K
- NPCE 205.3K
- Earning Date
- SPOK 10-29-2025
- NPCE 08-12-2025
- Dividend Yield
- SPOK 6.88%
- NPCE N/A
- EPS Growth
- SPOK 10.71
- NPCE N/A
- EPS
- SPOK 0.83
- NPCE N/A
- Revenue
- SPOK $140,742,000.00
- NPCE $88,570,000.00
- Revenue This Year
- SPOK $2.26
- NPCE $22.13
- Revenue Next Year
- SPOK $3.69
- NPCE $6.07
- P/E Ratio
- SPOK $21.87
- NPCE N/A
- Revenue Growth
- SPOK 1.79
- NPCE 23.32
- 52 Week Low
- SPOK $13.55
- NPCE $5.45
- 52 Week High
- SPOK $19.31
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- SPOK 48.35
- NPCE 51.74
- Support Level
- SPOK $17.61
- NPCE $8.61
- Resistance Level
- SPOK $18.15
- NPCE $8.99
- Average True Range (ATR)
- SPOK 0.33
- NPCE 0.53
- MACD
- SPOK -0.08
- NPCE 0.11
- Stochastic Oscillator
- SPOK 21.43
- NPCE 75.00
About SPOK Spok Holdings Inc.
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.